FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
-18.26%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$859M
AUM Growth
+$859M
(-24%)
Cap. Flow
-$1.67M
Cap. Flow
% of AUM
-0.19%
Top 10 Holdings %
Top 10 Hldgs %
49.67%
Holding
76
New
1
Increased
28
Reduced
17
Closed
5
Top Buys
| 1 |
NeoGenomics
NEO
|
$15.6M |
| 2 |
Crinetics Pharmaceuticals
CRNX
|
$12.3M |
| 3 |
SI-BONE Inc
SIBN
|
$12.2M |
| 4 |
Axogen
AXGN
|
$4.93M |
| 5 |
AtriCure
ATRC
|
$4.69M |
Top Sells
| 1 |
Halozyme
HALO
|
$28.9M |
| 2 |
XENT
Intersect ENT, Inc
XENT
|
$19.6M |
| 3 |
Sutro Biopharma
STRO
|
$13.7M |
| 4 |
Krystal Biotech
KRYS
|
$8.03M |
| 5 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
$5.1M |
Sector Composition
| 1 | Healthcare | 86.58% |
| 2 | Communication Services | 8.2% |
| 3 | Energy | 0.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MODN
1
DELISTED
MODEL N, INC.
MODN
| $70.4M | 8.2% | 2,753,758 +46,615 | +2% | +$1.19M |
|
|
2
AtriCure
ATRC
$1.84B
| $60.5M | 7.03% | 1,479,626 +114,814 | +8% | +$4.69M |
|
3
Prothena Corp
PRTA
$441M
| $52.6M | 6.12% | 1,938,183 +99,635 | +5% | +$2.71M |
|
|
4
Halozyme
HALO
$8.56B
| $41.4M | 4.82% | 941,245 -656,284 | -41% | -$28.9M |
|
|
SPNE
5
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $39.7M | 4.62% | 7,030,309 +24,521 | +0.4% | +$139K |
|
6
Omnicell
OMCL
$1.5B
| $39.5M | 4.59% | 347,029 +25,267 | +8% | +$2.87M |
|
|
7
Krystal Biotech
KRYS
$4.27B
| $39.1M | 4.55% | 595,612 -122,324 | -17% | -$8.03M |
|
|
CUTR
8
DELISTED
Cutera, Inc.
CUTR
| $28.9M | 3.37% | 771,814 -2,413 | -0.3% | -$90.5K |
|
9
Tandem Diabetes Care
TNDM
$845M
| $27.7M | 3.22% | 467,555 +32,250 | +7% | +$1.91M |
|
10
Ultragenyx Pharmaceutical
RARE
$2.89B
| $27M | 3.14% | 452,470 +14,958 | +3% | +$892K |
|
|
11
SI-BONE Inc
SIBN
$719M
| $26.5M | 3.08% | 2,006,304 +921,670 | +85% | +$12.2M |
|
|
12
Axogen
AXGN
$743M
| $24.8M | 2.88% | 3,025,119 +601,784 | +25% | +$4.93M |
|
|
13
Crinetics Pharmaceuticals
CRNX
$2.92B
| $23.1M | 2.69% | 1,240,609 +657,842 | +113% | +$12.3M |
|
|
BLU
14
DELISTED
BELLUS Health Inc.
BLU
| $22.3M | 2.59% | 2,408,074 -83,269 | -3% | -$769K |
|
|
15
NeoGenomics
NEO
$1.13B
| $22.1M | 2.58% | 2,715,487 +1,909,529 | +237% | +$15.6M |
|
|
FNA
16
DELISTED
Paragon 28, Inc.
FNA
| $19.6M | 2.29% | 1,237,511 +118,908 | +11% | +$1.89M |
|
17
Alphatec Holdings
ATEC
$2.35B
| $19.1M | 2.23% | 2,924,964 +206,844 | +8% | +$1.35M |
|
|
AXNX
18
DELISTED
Axonics, Inc. Common Stock
AXNX
| $17.8M | 2.07% | 314,004 +34,494 | +12% | +$1.95M |
|
19
CareDx
CDNA
$727M
| $16.7M | 1.94% | 776,620 +54,547 | +8% | +$1.17M |
|
20
Keros Therapeutics
KROS
$618M
| $16.5M | 1.92% | 598,333 -59,812 | -9% | -$1.65M |
|
21
Health Catalyst
HCAT
$239M
| $16.4M | 1.91% | 1,135,165 +276,432 | +32% | +$4.01M |
|
|
KRTX
22
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $15.9M | 1.85% | 125,793 +8,924 | +8% | +$1.13M |
|
23
KORU Medical Systems
KRMD
$195M
| $15.4M | 1.8% | 6,102,934 +3,114 | +0.1% | +$7.88K |
|
24
Insmed
INSM
$28.8B
| $15M | 1.75% | 762,182 +24,388 | +3% | +$481K |
|
|
NGM
25
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $14.6M | 1.69% | 1,135,884 +319,231 | +39% | +$4.09M |
|